DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 53 filers reported holding DESIGN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,328,638 | -62.4% | 986,711 | +0.3% | 0.00% | – |
| Q2 2023 | $6,194,627 | -16.3% | 983,274 | -23.4% | 0.00% | – |
| Q1 2023 | $7,403,158 | -53.8% | 1,283,043 | -17.8% | 0.00% | – |
| Q4 2022 | $16,023,042 | -38.2% | 1,561,700 | +0.6% | 0.00% | -100.0% |
| Q3 2022 | $25,946,000 | +44.8% | 1,551,750 | +21.2% | 0.00% | 0.0% |
| Q2 2022 | $17,920,000 | -40.8% | 1,280,044 | -31.7% | 0.00% | 0.0% |
| Q1 2022 | $30,263,000 | -24.4% | 1,873,893 | +0.2% | 0.00% | 0.0% |
| Q4 2021 | $40,047,000 | +150.5% | 1,870,502 | +71.9% | 0.00% | – |
| Q3 2021 | $15,986,000 | -33.4% | 1,088,201 | -9.8% | 0.00% | -100.0% |
| Q2 2021 | $23,986,000 | +541.7% | 1,205,966 | +864.8% | 0.00% | – |
| Q1 2021 | $3,738,000 | – | 124,991 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 6,526,476 | $37,657,767 | 14.03% |
| Logos Global Management LP | 2,797,501 | $16,141,581 | 2.31% |
| Cormorant Asset Management, LP | 5,150,000 | $29,716 | 1.96% |
| RA Capital Management | 2,971,231 | $17,144,003 | 0.39% |
| Avoro Capital Advisors LLC | 3,500,000 | $20,195,000 | 0.30% |
| Rock Springs Capital Management LP | 460,391 | $2,656,456 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 97,900 | $565 | 0.06% |
| PDT Partners, LLC | 59,969 | $346,021 | 0.05% |
| Ergoteles LLC | 177,337 | $1,023,234 | 0.04% |
| Atom Investors LP | 11,890 | $68,605 | 0.04% |